サマリー

Infectious Disease Drugs are drugs that relieve symptoms, resolve symptoms, or block the route of transmission.
The epidemic of infectious diseases has risen, spending has increased to increase the penetration of treatments for these diseases, initiatives to increase treatment awareness and awareness of these diseases, and increased clinical trial research on new drug development. The infectious disease drug market expanded.

Market Analysis and Insights: Global Infectious Disease Drugs Market
The global Infectious Disease Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Infectious Disease Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Infectious Disease Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Infectious Disease Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Infectious Disease Drugs market.

Global Infectious Disease Drugs Scope and Market Size
Infectious Disease Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Disease Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Antibacterials
Antiviral drugs
Antiparasitic drugs
Antifungal
Others

Segment by Application
HIV
Malaria
Hepatitis
Influenza
HPV
Tuberculosis
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline
Gilead Sciences
Merck & Co.
Pfizer
Sanofi
AbbVie
Shire
Grifols
Johnson & Johnson
Protein Sciences
AstraZeneca

ページTOPに戻る

目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antibacterials
1.2.3 Antiviral drugs
1.2.4 Antiparasitic drugs
1.2.5 Antifungal
1.2.6 Others
1.3 Market by Application
1.3.1 Global Infectious Disease Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 HIV
1.3.3 Malaria
1.3.4 Hepatitis
1.3.5 Influenza
1.3.6 HPV
1.3.7 Tuberculosis
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Infectious Disease Drugs Market Perspective (2016-2027)
2.2 Infectious Disease Drugs Growth Trends by Regions
2.2.1 Infectious Disease Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Infectious Disease Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Infectious Disease Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Infectious Disease Drugs Industry Dynamic
2.3.1 Infectious Disease Drugs Market Trends
2.3.2 Infectious Disease Drugs Market Drivers
2.3.3 Infectious Disease Drugs Market Challenges
2.3.4 Infectious Disease Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Drugs Players by Revenue
3.1.1 Global Top Infectious Disease Drugs Players by Revenue (2016-2021)
3.1.2 Global Infectious Disease Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Infectious Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Infectious Disease Drugs Revenue
3.4 Global Infectious Disease Drugs Market Concentration Ratio
3.4.1 Global Infectious Disease Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Drugs Revenue in 2020
3.5 Infectious Disease Drugs Key Players Head office and Area Served
3.6 Key Players Infectious Disease Drugs Product Solution and Service
3.7 Date of Enter into Infectious Disease Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Infectious Disease Drugs Breakdown Data by Type
4.1 Global Infectious Disease Drugs Historic Market Size by Type (2016-2021)
4.2 Global Infectious Disease Drugs Forecasted Market Size by Type (2022-2027)

5 Infectious Disease Drugs Breakdown Data by Application
5.1 Global Infectious Disease Drugs Historic Market Size by Application (2016-2021)
5.2 Global Infectious Disease Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Infectious Disease Drugs Market Size (2016-2027)
6.2 North America Infectious Disease Drugs Market Size by Type
6.2.1 North America Infectious Disease Drugs Market Size by Type (2016-2021)
6.2.2 North America Infectious Disease Drugs Market Size by Type (2022-2027)
6.2.3 North America Infectious Disease Drugs Market Size by Type (2016-2027)
6.3 North America Infectious Disease Drugs Market Size by Application
6.3.1 North America Infectious Disease Drugs Market Size by Application (2016-2021)
6.3.2 North America Infectious Disease Drugs Market Size by Application (2022-2027)
6.3.3 North America Infectious Disease Drugs Market Size by Application (2016-2027)
6.4 North America Infectious Disease Drugs Market Size by Country
6.4.1 North America Infectious Disease Drugs Market Size by Country (2016-2021)
6.4.2 North America Infectious Disease Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Infectious Disease Drugs Market Size (2016-2027)
7.2 Europe Infectious Disease Drugs Market Size by Type
7.2.1 Europe Infectious Disease Drugs Market Size by Type (2016-2021)
7.2.2 Europe Infectious Disease Drugs Market Size by Type (2022-2027)
7.2.3 Europe Infectious Disease Drugs Market Size by Type (2016-2027)
7.3 Europe Infectious Disease Drugs Market Size by Application
7.3.1 Europe Infectious Disease Drugs Market Size by Application (2016-2021)
7.3.2 Europe Infectious Disease Drugs Market Size by Application (2022-2027)
7.3.3 Europe Infectious Disease Drugs Market Size by Application (2016-2027)
7.4 Europe Infectious Disease Drugs Market Size by Country
7.4.1 Europe Infectious Disease Drugs Market Size by Country (2016-2021)
7.4.2 Europe Infectious Disease Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Drugs Market Size (2016-2027)
8.2 Asia-Pacific Infectious Disease Drugs Market Size by Type
8.2.1 Asia-Pacific Infectious Disease Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Infectious Disease Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Infectious Disease Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Infectious Disease Drugs Market Size by Application
8.3.1 Asia-Pacific Infectious Disease Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Infectious Disease Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Infectious Disease Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Infectious Disease Drugs Market Size by Region
8.4.1 Asia-Pacific Infectious Disease Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Infectious Disease Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Infectious Disease Drugs Market Size (2016-2027)
9.2 Latin America Infectious Disease Drugs Market Size by Type
9.2.1 Latin America Infectious Disease Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Infectious Disease Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Infectious Disease Drugs Market Size by Type (2016-2027)
9.3 Latin America Infectious Disease Drugs Market Size by Application
9.3.1 Latin America Infectious Disease Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Infectious Disease Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Infectious Disease Drugs Market Size by Application (2016-2027)
9.4 Latin America Infectious Disease Drugs Market Size by Country
9.4.1 Latin America Infectious Disease Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Infectious Disease Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Drugs Market Size (2016-2027)
10.2 Middle East & Africa Infectious Disease Drugs Market Size by Type
10.2.1 Middle East & Africa Infectious Disease Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Infectious Disease Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Infectious Disease Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Infectious Disease Drugs Market Size by Application
10.3.1 Middle East & Africa Infectious Disease Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Infectious Disease Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Infectious Disease Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Infectious Disease Drugs Market Size by Country
10.4.1 Middle East & Africa Infectious Disease Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Infectious Disease Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Infectious Disease Drugs Introduction
11.1.4 GlaxoSmithKline Revenue in Infectious Disease Drugs Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Infectious Disease Drugs Introduction
11.2.4 Gilead Sciences Revenue in Infectious Disease Drugs Business (2016-2021)
11.2.5 Gilead Sciences Recent Development
11.3 Merck & Co.
11.3.1 Merck & Co. Company Details
11.3.2 Merck & Co. Business Overview
11.3.3 Merck & Co. Infectious Disease Drugs Introduction
11.3.4 Merck & Co. Revenue in Infectious Disease Drugs Business (2016-2021)
11.3.5 Merck & Co. Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Infectious Disease Drugs Introduction
11.4.4 Pfizer Revenue in Infectious Disease Drugs Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Infectious Disease Drugs Introduction
11.5.4 Sanofi Revenue in Infectious Disease Drugs Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Infectious Disease Drugs Introduction
11.6.4 AbbVie Revenue in Infectious Disease Drugs Business (2016-2021)
11.6.5 AbbVie Recent Development
11.7 Shire
11.7.1 Shire Company Details
11.7.2 Shire Business Overview
11.7.3 Shire Infectious Disease Drugs Introduction
11.7.4 Shire Revenue in Infectious Disease Drugs Business (2016-2021)
11.7.5 Shire Recent Development
11.8 Grifols
11.8.1 Grifols Company Details
11.8.2 Grifols Business Overview
11.8.3 Grifols Infectious Disease Drugs Introduction
11.8.4 Grifols Revenue in Infectious Disease Drugs Business (2016-2021)
11.8.5 Grifols Recent Development
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Details
11.9.2 Johnson & Johnson Business Overview
11.9.3 Johnson & Johnson Infectious Disease Drugs Introduction
11.9.4 Johnson & Johnson Revenue in Infectious Disease Drugs Business (2016-2021)
11.9.5 Johnson & Johnson Recent Development
11.10 Protein Sciences
11.10.1 Protein Sciences Company Details
11.10.2 Protein Sciences Business Overview
11.10.3 Protein Sciences Infectious Disease Drugs Introduction
11.10.4 Protein Sciences Revenue in Infectious Disease Drugs Business (2016-2021)
11.10.5 Protein Sciences Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Details
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Infectious Disease Drugs Introduction
11.11.4 AstraZeneca Revenue in Infectious Disease Drugs Business (2016-2021)
11.11.5 AstraZeneca Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details